Results 111 to 120 of about 6,579 (240)

Current State of Evidence for Use of MRI in LI‐RADS

open access: yesJournal of Magnetic Resonance Imaging, Volume 62, Issue 3, Page 640-653, September 2025.
ABSTRACT The American College of Radiology Liver Imaging Reporting and Data System (LI‐RADS) is the preeminent framework for classification and risk stratification of liver observations on imaging in patients at high risk for hepatocellular carcinoma.
Ameya Madhav Kulkarni   +10 more
wiley   +1 more source

Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan

open access: yesJournal of the Formosan Medical Association, 2018
Background: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality in Taiwan. To help clinical physicians to manage patients with HCC, the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan ...
Sheng-Nan Lu   +77 more
doaj   +1 more source

Stage‐specific characterization of “early‐onset colorectal cancer”: Localized and synchronous metastatic disease

open access: yesInternational Journal of Cancer, Volume 156, Issue 12, Page 2340-2351, 15 June 2025.
What's New? The incidence of early‐onset colorectal cancer (EOCRC) has been raising, and stage‐specific characteristics and prognosis need to be clarified. In this study, more than 90% of EOCRC cases presented with symptoms. Among patients with localized cancer, female gender, perineural invasion, and intense treatment were more frequent in early than ...
Erman Akkus   +5 more
wiley   +1 more source

Beyond Hepatocellular Carcinoma and Colorectal Metastasis: The Expanding Applications of Radioembolization [PDF]

open access: yes, 2014
As a relatively safe outpatient procedure, radioembolization can potentially be used to treat any type of tumor within the liver, primary or metastatic.
Ganguli, Suvranu, Zurkiya, Omar
core   +2 more sources

Dynamic Lymphocyte Changes Following Transarterial Radioembolization: Association with Normal Liver Dose and Effect on Overall Survival

open access: yesJournal of Hepatocellular Carcinoma, 2022
Shamar Young,1 Ranjan Ragulojan,1 Ting Chen,1 Joshua Owen,1 Donna D’souza,1 Tina Sanghvi,2 Jafar Golzarian,1 Siobhan Flanagan1 1University of Minnesota, Department of Radiology, Division of Interventional Radiology, Minneapolis, MN, 55455, USA ...
Young S   +7 more
doaj  

Downstaging for hepatocellular cancer: Harm or benefit? [PDF]

open access: yes, 2017
Downstaging of hepatocellular carcinoma (HCC) to enable liver transplantation has become an area of intense interest and research. It may allow a curative option in patients outside widely accepted transplantation criteria, with outcomes that, in some ...
Bryce, K, Tsochatzis, EA
core   +1 more source

Multimodality Treatment for Early-Stage Hepatocellular Carcinoma: A Bridging Therapy for Liver Transplantation [PDF]

open access: yes, 2012
Purpose: To evaluate the efficiency of a multimodality approach consisting of transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) as bridging therapy for patients with hepatocellular carcinoma (HCC) awaiting orthotopic liver
A. Peporte   +16 more
core   +2 more sources

Yttrium-90 radioembolization for treatment of anaplastic meningioma liver metastases

open access: yesRadiology Case Reports
Meningiomas are the most common primary intracranial neoplasm. The WHO classification, focusing on histomorphologic and molecular features, distinguishes WHO grade -1, -2, and -3 tumors.
Mohammad-Kasim Fassia   +9 more
doaj   +1 more source

Locoregional Therapies for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease

open access: yesBiomedicines
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide with an average five-year survival rate in the US of 19.6%.
Stephen Susman   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy